miR-29c is downregulated in renal interstitial fibrosis in humans and rats and restored by HIF-α activation. - Wikidata - awgldk - TriplyDB

miR-29c is downregulated in renal interstitial fibrosis in humans and rats and restored by HIF-α activation.

miR-29c is downregulated in renal interstitial fibrosis in humans and rats and restored by HIF-α activation.

http://www.wikidata.org/entity/Q36836214

about

Regulatory Mechanisms of the Molecular Pathways in Fibrosis Induced by MicroRNAs Mini-review: emerging roles of microRNAs in the pathophysiology of renal diseases Role of the microRNA-29 family in fibrotic skin diseases.Hypoxia, HIF, and Associated Signaling Networks in Chronic Kidney Disease.miR-382 Contributes to Renal Tubulointerstitial Fibrosis by Downregulating HSPD1.Urinary miR-29 correlates with albuminuria and carotid intima-media thickness in type 2 diabetes patients.Myocardial fibrosis induced by exposure to subclinical lipopolysaccharide is associated with decreased miR-29c and enhanced NOX2 expression in mice Downregulated miR-29c correlates with increased BACE1 expression in sporadic Alzheimer's disease.microRNA-29b prevents liver fibrosis by attenuating hepatic stellate cell activation and inducing apoptosis through targeting PI3K/AKT pathway.Different regulation of miR-29a-3p in glomeruli and tubules in an experimental model of angiotensin II-dependent hypertension: potential role in renal fibrosis.MicroRNAs as novel therapeutic targets to treat kidney injury and fibrosis.MicroRNA-210 Plays a Critical Role in the Angiogenic Effect of Isoprenaline on Human Umbilical Vein Endothelial Cells via Regulation of Noncoding RNAs Alpinia oxyphylla Miq. extract changes miRNA expression profiles in db-/db- mouse kidney The signaling pathway of hypoxia inducible factor and its role in renal diseases.MicroRNAs in IgA nephropathy.Role of microRNA machinery in kidney fibrosis.Hypoxia-sensitive pathways in inflammation-driven fibrosis.Biomarkers in IgA nephropathy.Epigenetics in idiopathic pulmonary fibrosis.miRNAs in urine: a mirror image of kidney disease?microRNAs in glomerular diseases from pathophysiology to potential treatment target.Novel Biomarkers in the Diagnosis of Chronic Kidney Disease and the Prediction of Its Outcome.Extracellular microRNA signature in chronic kidney disease.Regulation of LOXL2 and SERPINH1 by antitumor microRNA-29a in lung cancer with idiopathic pulmonary fibrosis.MicroRNA-29: A Crucial Player in Fibrotic Disease.The Tubulointerstitial Pathophysiology of Progressive Kidney Disease.Hypoxia Inducible Factor (HIF) Hydroxylases as Regulators of Intestinal Epithelial Barrier Function.Novel Anti-fibrotic Therapies.MicroRNA-489 Induction by Hypoxia-Inducible Factor-1 Protects against Ischemic Kidney Injury.Renal Protection Mediated by Hypoxia Inducible Factor-1α Depends on Proangiogenesis Function of miR-21 by Targeting Thrombospondin 1.Hypoxia-inducible factor-1α promotes glomerulosclerosis and regulates COL1A2 expression through interactions with Smad3.MicroRNA and Renal Allograft Monitoring miR-21-5p renal expression is associated with fibrosis and renal survival in patients with IgA nephropathy.MicroRNA-29c in urinary exosome/microvesicle as a biomarker of renal fibrosis.Hydroxylase inhibition regulates inflammation-induced intestinal fibrosis through the suppression of ERK-mediated TGF-β1 signaling. [corrected].Cardiac myocyte miR-29 promotes pathological remodeling of the heart by activating Wnt signaling.Differential expression of urinary exosomal microRNAs in IgA nephropathy.MicroRNAs: a new avenue to understand, investigate and treat immunoglobulin A nephropathy?A PEG-based method for the isolation of urinary exosomes and its application in renal fibrosis diagnostics using cargo miR-29c and miR-21 analysis.Therapeutic potential of microRNAs for the treatment of renal fibrosis and CKD.

P2860

Q28072792-1333704F-7987-4EFF-A853-0AAE445818AA Q28354033-5EF57DD9-FE59-44F5-9987-6C80EBD5B108 Q33742115-DAC7A002-2471-4C5C-B8F2-A73C5D4217A3 Q33754900-C9FBD11C-2018-41D0-A2F3-D5CF8E4B39F3 Q33820023-0354FBF9-04F7-46A0-B6A3-73ED3CCBF089 Q35070398-29863FF2-3689-4570-A908-A55888B2116F Q35261976-B7619D33-D5DD-467A-B06D-4E818BB7938B Q35405370-50AF4E91-DC03-44A5-B2B4-7801108DA7FA Q35740215-20CE7CC9-5832-4BD4-9A5D-DA76B14F3BD6 Q35877447-F3416E78-0E07-49B7-BCCA-952D8C3D9E5D Q37211825-4B09F2DC-E80C-4D1B-9C09-43BC6350E615 Q37447462-C1D1C875-2F56-409D-AB39-5EF88B15119E Q37673402-8FC1CE4F-AFF5-487F-9546-3E4A32CED106 Q38131006-DF845ED8-AE60-4A87-846B-651E5E4707DF Q38202828-F8ADE43D-443B-4109-AF44-B802EA818EB9 Q38209551-750F8843-7CC9-4832-8483-5BA6FA4BA6A6 Q38258327-F7E78913-F5F9-4C41-BC44-4C91D3A09810 Q38294669-3A44B58B-958E-4543-A6CD-AF4BE6DFC48E Q38346940-4AB43552-9817-4206-BEE5-7FC2235C17B8 Q38347455-88756CD0-2DD0-435A-AF09-3B0E58D6393A Q38424330-4F4744C5-594A-44BE-8451-68BF89730A7B Q38646836-358E38B5-C8CB-4CEC-A186-0F7F0FE2A37E Q38721838-690FECF5-3BDE-4A37-B832-C9282B1ABB46 Q38754000-465C484F-CA1E-4AA4-8283-C226F8AAE383 Q39107249-5708029B-74BA-43B2-8BA8-9932AC8ACD82 Q39173994-F2FAD54D-17BD-40D5-9906-57DB077E2CBE Q39277299-EDE35B90-9E28-49E3-8AA8-1494F6B641AD Q39377055-A21CAFBC-8F3D-4FB7-8FFC-D4B59E31ECC3 Q40974313-BFB2B86F-C7B9-4E6F-B3FD-9369056A5A04 Q41239969-3BD0E72F-7DDD-4FFA-9249-C29190171A51 Q41652349-2065CD7D-A9F1-401D-A1EF-079A94127D46 Q42017986-41337D54-40FF-49F3-A23E-6D35649AF3E2 Q42140252-10E9C1EB-3901-4644-A508-CE6DECAF79CE Q44259722-32229644-4389-4665-8101-B3B7A8B89D9F Q46623958-2A07DD74-0427-449B-BE3F-BDDABC064174 Q46632595-0709AD39-9652-4B22-81BD-0376D317D6B0 Q48313044-6ED32312-E03E-442D-BBE3-80896D59E9A8 Q49626137-6F4F52E5-9ACB-494A-8D53-79F078D8EC6C Q50057516-3BDB093C-6D53-46E3-9327-B1E72496D568 Q50063239-97B4B0E5-8EA1-49F7-8297-8B8B446F3410

P2860

miR-29c is downregulated in renal interstitial fibrosis in humans and rats and restored by HIF-α activation.

http://www.wikidata.org/entity/Q36836214

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

miR-29c is downregulated in re ...... restored by HIF-α activation.

@en

type

label

miR-29c is downregulated in re ...... restored by HIF-α activation.

@en

prefLabel

miR-29c is downregulated in re ...... restored by HIF-α activation.

@en

P1433

Q36836214-ACF39BF4-7F9D-40F4-BC7F-718B261CC167

P1476

Q36836214-C8CF3EE9-9ED7-40A6-AC0F-82AF4D20E020

P2093

Q36836214-55C0FD43-6EFB-4BA1-BC1D-7947BA20751B

Q36836214-55C47A04-DBD4-48BF-B7A0-3B2065F5B22C

Q36836214-626AFE14-1ED5-4316-8B44-F01A06177613

Q36836214-6DB52492-5CF1-40C3-B88C-B6BBA08C20EE

Q36836214-753B4028-C2C5-4278-8244-6FF2F3547D88

Q36836214-DA7E32B7-B111-4704-BD6C-A9D8CD17BDDC

Q36836214-E08D9FA7-42EE-43FB-9F6B-1C257BA28D21

Q36836214-E2C2F77B-20EE-4DE0-BDD9-67E3163AF6DA

P2860

Q36836214-0112DA51-A283-4A93-B076-22CBEB654177

Q36836214-03E3452D-603C-4038-A3DA-2064D5C0B5D0

Q36836214-10D7CAA4-4C04-47CE-9610-C596C3967766

Q36836214-16535EE5-81A4-4672-A15D-4760CBF89101

Q36836214-1B8630EF-6A64-4155-A74D-DEE17817D2D9

Q36836214-20E18D11-63BD-467E-B95E-C27611C4A32C

Q36836214-25532EE9-528C-477E-9822-6957E8C6A3B0

Q36836214-2855B047-3B1F-434B-AD4E-43720DC24DD5

Q36836214-28864E06-FE9E-4F33-AE05-F8360D16CDCD

Q36836214-37C0E0FE-9154-42D3-936A-34E9D48BB3E2

P304

Q36836214-7E491D53-8667-4773-A01D-76498E147334

P31

Q36836214-A8F745FA-C0D8-421C-BC39-D41898A89A7F

P356

Q36836214-3A0C9A79-EA6D-461F-8AD1-A1E48EA926F8

P433

Q36836214-07E1F445-CE54-46A9-B68F-9ECA57FE5000

P478

Q36836214-17463B8B-183B-46C5-8834-A67A66D74014

P577

Q36836214-AF598793-C892-4881-8FB0-E1755EE0CC50

P5875

Q36836214-D9CE18C6-7C4A-44F9-81BA-8A13C8AD4A0C

P698

Q36836214-AC7C3FEA-5973-4F06-8380-4FDE60E0DDAD

P932

Q36836214-49BD888B-D68A-49C0-9D69-EC8BC87092E4

P356

AJPRENAL.00287.2012

P1433

American Journal of Physiology - Renal Physiology

P1476

miR-29c is downregulated in re ...... restored by HIF-α activation.

@en

P2093

Alison J Kriegel

http://www.w3.org/2001/XMLSchema#string

Mingyu Liang

http://www.w3.org/2001/XMLSchema#string

Xialian Xu

http://www.w3.org/2001/XMLSchema#string

Xiaofang Yu

http://www.w3.org/2001/XMLSchema#string

Xiaoqiang Ding

http://www.w3.org/2001/XMLSchema#string

Yanyan Heng

http://www.w3.org/2001/XMLSchema#string

Yi Fang

http://www.w3.org/2001/XMLSchema#string

Yong Liu

http://www.w3.org/2001/XMLSchema#string

P2860

MiRNA-directed regulation of VEGF and other angiogenic factors under hypoxia

The RIN: an RNA integrity number for assigning integrity values to RNA measurements

Epithelial-mesenchymal transition and its implications for fibrosis

Silencing of the Tropomyosin-1 gene by DNA methylation alters tumor suppressor function of TGF-beta

Role of high-molecular weight tropomyosins in TGF-beta-mediated control of cell motility

Widespread microRNA repression by Myc contributes to tumorigenesis

Dual roles of myocardin-related transcription factors in epithelial mesenchymal transition via slug induction and actin remodeling

Towards standardization of RNA quality assessment using user-independent classifiers of microcapillary electrophoresis traces

MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins.

Breakthrough of the year. Small RNAs make big splash

P304

F1274-82

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1152/AJPRENAL.00287.2012

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

304

http://www.w3.org/2001/XMLSchema#string

P577

2013-03-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235881528

http://www.w3.org/2001/XMLSchema#string

P698

23467423

http://www.w3.org/2001/XMLSchema#string

P932

3651624

http://www.w3.org/2001/XMLSchema#string